ASX - By Stock
|
RAD |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
HoseHurley
|
15 |
3.4K |
0 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
15
|
3.4K
|
0
|
|
ASX - By Stock
|
NHE |
Re:
valuation of possible discovery
|
|
HoseHurley
|
47 |
15K |
0 |
01/11/23 |
01/11/23 |
ASX - By Stock
|
47
|
15K
|
0
|
|
ASX - By Stock
|
NHE |
Re:
Ann: Drilling commences at Mbelele-1
|
|
HoseHurley
|
15 |
4.4K |
7 |
27/10/23 |
27/10/23 |
ASX - By Stock
|
15
|
4.4K
|
7
|
|
ASX - By Stock
|
NHE |
Re:
What's the chances?
|
|
HoseHurley
|
24 |
8.6K |
0 |
19/10/23 |
19/10/23 |
ASX - By Stock
|
24
|
8.6K
|
0
|
|
ASX - By Stock
|
NHE |
Re:
Now where talkin
|
|
HoseHurley
|
16 |
5.4K |
0 |
13/10/23 |
13/10/23 |
ASX - By Stock
|
16
|
5.4K
|
0
|
|
ASX - By Stock
|
NHE |
Re:
Ann: Operations Update
|
|
HoseHurley
|
15 |
5.6K |
1 |
15/09/23 |
15/09/23 |
ASX - By Stock
|
15
|
5.6K
|
1
|
|
ASX - By Stock
|
NHE |
Re:
Ann: New Ngambwa Lead at North Rukwa Project
|
|
HoseHurley
|
24 |
7.5K |
3 |
06/09/23 |
06/09/23 |
ASX - By Stock
|
24
|
7.5K
|
3
|
|
ASX - By Stock
|
NHE |
Re:
Ann: Operations Update
|
|
HoseHurley
|
1 |
881 |
4 |
15/08/23 |
15/08/23 |
ASX - By Stock
|
1
|
881
|
4
|
|
ASX - By Stock
|
NHE |
Re:
Ann: Marriott Rig mobilising for North Rukwa
|
|
HoseHurley
|
44 |
13K |
1 |
11/08/23 |
11/08/23 |
ASX - By Stock
|
44
|
13K
|
1
|
|
ASX - By Stock
|
NHE |
Re:
Ann: Marriott Rig mobilising for North Rukwa
|
|
HoseHurley
|
44 |
13K |
5 |
09/08/23 |
09/08/23 |
ASX - By Stock
|
44
|
13K
|
5
|
|
ASX - By Stock
|
NHE |
Re:
Ann: Marriott Rig mobilising for North Rukwa
|
|
HoseHurley
|
44 |
13K |
5 |
07/08/23 |
07/08/23 |
ASX - By Stock
|
44
|
13K
|
5
|
|
ASX - By Stock
|
RAD |
Re:
Ann: Pivalate educational webinar 14 June 2023
|
|
HoseHurley
|
17 |
7.3K |
0 |
27/06/23 |
27/06/23 |
ASX - By Stock
|
17
|
7.3K
|
0
|
|
ASX - By Stock
|
RAD |
Re:
Ann: Pivalate educational webinar 14 June 2023
|
|
HoseHurley
|
17 |
7.3K |
0 |
26/06/23 |
26/06/23 |
ASX - By Stock
|
17
|
7.3K
|
0
|
|
ASX - By Stock
|
RAD |
Re:
Ann: Pivalate educational webinar 14 June 2023
|
|
HoseHurley
|
17 |
7.3K |
3 |
26/06/23 |
26/06/23 |
ASX - By Stock
|
17
|
7.3K
|
3
|
|
ASX - By Stock
|
NHE |
Re:
Ann: $13.5 million Placement for Drilling at North Rukwa Project
|
|
HoseHurley
|
18 |
5.9K |
1 |
23/06/23 |
23/06/23 |
ASX - By Stock
|
18
|
5.9K
|
1
|
|
ASX - By Stock
|
NHE |
Re:
Ann: $13.5 million Placement for Drilling at North Rukwa Project
|
|
HoseHurley
|
18 |
5.9K |
1 |
21/06/23 |
21/06/23 |
ASX - By Stock
|
18
|
5.9K
|
1
|
|
ASX - By Stock
|
RAD |
Re:
News: RAD Radiopharm Theranostics Says U.S. FDA Granted Orphan Drug Designation To GA68-TRIVEHEXIN
|
|
HoseHurley
|
73 |
23K |
1 |
07/06/23 |
07/06/23 |
ASX - By Stock
|
73
|
23K
|
1
|
|
ASX - By Stock
|
RAD |
Re:
News: RAD Radiopharm Theranostics Says U.S. FDA Granted Orphan Drug Designation To GA68-TRIVEHEXIN
|
|
HoseHurley
|
73 |
23K |
1 |
07/06/23 |
07/06/23 |
ASX - By Stock
|
73
|
23K
|
1
|
|
ASX - By Stock
|
RAD |
Re:
News: RAD Radiopharm Theranostics Says U.S. FDA Granted Orphan Drug Designation To GA68-TRIVEHEXIN
|
|
HoseHurley
|
73 |
23K |
0 |
07/06/23 |
07/06/23 |
ASX - By Stock
|
73
|
23K
|
0
|
|
ASX - By Stock
|
RAD Biotech |
Re:
RAD media and Publications
|
|
HoseHurley
|
171 |
66K |
3 |
01/06/23 |
01/06/23 |
ASX - By Stock
|
171
|
66K
|
3
|
|
ASX - By Stock
|
RAD |
Re:
News: RAD Radiopharm Theranostics Says U.S. FDA Granted Orphan Drug Designation To GA68-TRIVEHEXIN
|
|
HoseHurley
|
73 |
23K |
0 |
26/05/23 |
26/05/23 |
ASX - By Stock
|
73
|
23K
|
0
|
|
ASX - By Stock
|
RAD |
Re:
News: RAD Radiopharm Theranostics Says U.S. FDA Granted Orphan Drug Designation To GA68-TRIVEHEXIN
|
|
HoseHurley
|
73 |
23K |
1 |
24/05/23 |
24/05/23 |
ASX - By Stock
|
73
|
23K
|
1
|
|
ASX - By Stock
|
RAD |
Re:
News: RAD Radiopharm Theranostics Says U.S. FDA Granted Orphan Drug Designation To GA68-TRIVEHEXIN
|
|
HoseHurley
|
73 |
23K |
0 |
24/05/23 |
24/05/23 |
ASX - By Stock
|
73
|
23K
|
0
|
|
ASX - By Stock
|
RAD Biotech |
Re:
RAD media and Publications
|
|
HoseHurley
|
171 |
66K |
0 |
18/05/23 |
18/05/23 |
ASX - By Stock
|
171
|
66K
|
0
|
|
ASX - By Stock
|
RAD Biotech |
Re:
RAD media and Publications
|
|
HoseHurley
|
171 |
66K |
0 |
18/05/23 |
18/05/23 |
ASX - By Stock
|
171
|
66K
|
0
|
|
ASX - By Stock
|
RAD Biotech |
Re:
RAD media and Publications
|
|
HoseHurley
|
171 |
66K |
2 |
17/05/23 |
17/05/23 |
ASX - By Stock
|
171
|
66K
|
2
|
|
ASX - By Stock
|
RAD Biotech |
Re:
RAD media and Publications
|
|
HoseHurley
|
171 |
66K |
0 |
17/05/23 |
17/05/23 |
ASX - By Stock
|
171
|
66K
|
0
|
|
ASX - By Stock
|
RAD |
Re:
News: RAD Radiopharm Theranostics Says U.S. FDA Granted Orphan Drug Designation To GA68-TRIVEHEXIN
|
|
HoseHurley
|
73 |
23K |
6 |
12/05/23 |
12/05/23 |
ASX - By Stock
|
73
|
23K
|
6
|
|
ASX - By Stock
|
RAD |
Re:
News: RAD Radiopharm Theranostics Says U.S. FDA Granted Orphan Drug Designation To GA68-TRIVEHEXIN
|
|
HoseHurley
|
73 |
23K |
5 |
10/05/23 |
10/05/23 |
ASX - By Stock
|
73
|
23K
|
5
|
|
ASX - By Stock
|
RAD |
Re:
News: RAD Radiopharm Theranostics Says U.S. FDA Granted Orphan Drug Designation To GA68-TRIVEHEXIN
|
|
HoseHurley
|
73 |
23K |
4 |
10/05/23 |
10/05/23 |
ASX - By Stock
|
73
|
23K
|
4
|
|
ASX - By Stock
|
RAD |
Re:
Ann: Radiopharm Theranostics initiates process for Nasdaq listing
|
|
HoseHurley
|
50 |
20K |
2 |
12/04/23 |
12/04/23 |
ASX - By Stock
|
50
|
20K
|
2
|
|
ASX - By Stock
|
RAD |
Re:
Ann: RAD to present at virtual healthcare conference
|
|
HoseHurley
|
85 |
24K |
6 |
17/03/23 |
17/03/23 |
ASX - By Stock
|
85
|
24K
|
6
|
|
ASX - By Stock
|
RAD |
Re:
Ann: Notice Under Section 708A
|
|
HoseHurley
|
21 |
4.8K |
0 |
10/03/23 |
10/03/23 |
ASX - By Stock
|
21
|
4.8K
|
0
|
|
ASX - By Stock
|
RAD |
Re:
Ann: Appendix 4D and Half Year Report
|
|
HoseHurley
|
22 |
4.9K |
2 |
01/03/23 |
01/03/23 |
ASX - By Stock
|
22
|
4.9K
|
2
|
|
ASX - By Stock
|
RAD |
Re:
Ann: Appendix 4D and Half Year Report
|
|
HoseHurley
|
22 |
4.9K |
5 |
28/02/23 |
28/02/23 |
ASX - By Stock
|
22
|
4.9K
|
5
|
|
ASX - By Stock
|
RAD Biotech |
Re:
RAD media and Publications
|
|
HoseHurley
|
171 |
66K |
3 |
21/02/23 |
21/02/23 |
ASX - By Stock
|
171
|
66K
|
3
|
|
ASX - By Stock
|
RAD Biotech |
Re:
RAD media and Publications
|
|
HoseHurley
|
171 |
66K |
3 |
21/02/23 |
21/02/23 |
ASX - By Stock
|
171
|
66K
|
3
|
|
ASX - By Stock
|
RAD |
Re:
Ann: Radiopharm Theranostics initiates process for Nasdaq listing
|
|
HoseHurley
|
50 |
20K |
2 |
18/02/23 |
18/02/23 |
ASX - By Stock
|
50
|
20K
|
2
|
|
ASX - By Stock
|
RAD |
Re:
Ann: Radiopharm Theranostics initiates process for Nasdaq listing
|
|
HoseHurley
|
50 |
20K |
4 |
18/02/23 |
18/02/23 |
ASX - By Stock
|
50
|
20K
|
4
|
|
ASX - By Stock
|
RAD |
Re:
Bell Potter Healthcare Conference 2022
|
|
HoseHurley
|
25 |
11K |
0 |
12/02/23 |
12/02/23 |
ASX - By Stock
|
25
|
11K
|
0
|
|
ASX - By Stock
|
RAD |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
HoseHurley
|
14 |
3.3K |
0 |
01/02/23 |
01/02/23 |
ASX - By Stock
|
14
|
3.3K
|
0
|
|
ASX - By Stock
|
RAD |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
HoseHurley
|
14 |
3.3K |
0 |
01/02/23 |
01/02/23 |
ASX - By Stock
|
14
|
3.3K
|
0
|
|
ASX - By Stock
|
RAD |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
HoseHurley
|
14 |
3.3K |
1 |
01/02/23 |
01/02/23 |
ASX - By Stock
|
14
|
3.3K
|
1
|
|
ASX - By Stock
|
RAD |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
HoseHurley
|
14 |
3.3K |
3 |
31/01/23 |
31/01/23 |
ASX - By Stock
|
14
|
3.3K
|
3
|
|
ASX - By Stock
|
RAD |
Re:
Ann: Dr. Rama Abu Shmeis appointed Senior VP, CMC
|
|
HoseHurley
|
21 |
7.4K |
0 |
12/01/23 |
12/01/23 |
ASX - By Stock
|
21
|
7.4K
|
0
|
|
ASX - By Stock
|
RAD |
Re:
Ann: aVb6 Integrin (RAD301) IND approval for Phase 1 trial
|
|
HoseHurley
|
18 |
8.8K |
8 |
04/01/23 |
04/01/23 |
ASX - By Stock
|
18
|
8.8K
|
8
|
|
ASX - By Stock
|
RAD |
Re:
Ann: aVb6 Integrin (RAD301) IND approval for Phase 1 trial
|
|
HoseHurley
|
18 |
8.8K |
8 |
02/01/23 |
02/01/23 |
ASX - By Stock
|
18
|
8.8K
|
8
|
|
Charts
|
A11 |
Re:
A11 Charts
|
|
HoseHurley
|
14 |
5.5K |
1 |
24/11/22 |
24/11/22 |
Charts
|
14
|
5.5K
|
1
|
|
ASX - By Stock
|
RAD |
Re:
Ann: Entitlement Offer - Letter to Eligible Retail Shareholders
|
|
HoseHurley
|
12 |
4.8K |
0 |
31/10/22 |
31/10/22 |
ASX - By Stock
|
12
|
4.8K
|
0
|
|
ASX - By Stock
|
RAD |
Re:
Ann: Suspension from Official Quotation
|
|
HoseHurley
|
75 |
20K |
0 |
19/10/22 |
19/10/22 |
ASX - By Stock
|
75
|
20K
|
0
|
|